IN VITRO DIAGNOSTICS Financings HTG Molecular Diagnostics Inc. HTG Molecular Diagnostics Inc. netted $37.9mm through a public offering of 13.9mm common shares (including the overallotment) at $2.9
In Vitro Diagnostics Mergers & Acquisitions /In Vitro Diagnostics Astellas Pharma Inc. Cell Signaling Technology Inc. Pfizer Inc. Cell Signaling Technology Inc. (CST; research tools for identifyin